Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
Carl Graham(King's College London), Katie J. Doores(King's College London)
Cited by 33
Related Papers
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
|Nature Microbiology|2020|1.4k
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
|Immunity|2021|167
Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
|Cell Reports|2025|6
Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans
|Cell Reports|2022|5
Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
|bioRxiv (Cold Spring Harbor Laboratory)|2025|2